Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1984 Jul;74(1):17–24. doi: 10.1172/JCI111398

Multicomponent analysis of amino acid transport in human lymphocytes. Diminished L-system transport in chronic leukemic B lymphocytes.

G B Segel, W Simon, M A Lichtman
PMCID: PMC425180  PMID: 6610691

Abstract

We have examined the amino acid transport in B cell chronic lymphocytic leukemia and compared it with the amino acid transport in isolated B lymphocytes from human blood and tonsils. L-system transport was measured with 2-amino-2-carboxy-bicyclo (2,2,1)-heptane, which is a synthetic amino acid whose transport is limited to the L-system. Amino acid uptake was subjected to a multicomponent analysis that partitioned the total uptake into the saturable carrier-mediated transport system and the uptake by diffusion. The maximal velocity of L-system transport in chronic lymphocytic leukemia cells, 81 mumol/1 cell water per min, was less than 10% that of blood B lymphocytes, which was 1,029 mumol/1 cell water per min. The uptake of 2-amino-2-carboxy-bicyclo (2,2,1)-heptane by tonsillar B cells, by a B lymphocyte cell line, and by blood T-lymphocytes was also 10-fold greater than that observed in chronic lymphocytic leukemic cells. Similarly, the L-system uptake of leucine and phenylalanine, which are naturally occurring amino acids usually transported primarily by the L-system, was reduced in chronic lymphocytic leukemic B cells to 15 and 10% of normal B cells, respectively. Total leucine uptake by chronic lymphocytic leukemic cells, however, was sustained at 30% of that expected because of transport via an alternative transport system. The A- or ASC-systems, the other major amino acid transport pathways, were not defective in chronic lymphocytic leukemic cells. These data indicate that there is a specific, profound decrease in L-system carrier-mediated amino acid transport in chronic lymphocytic leukemic B cells, as judged by the system-specific synthetic amino acid, 2-amino-2-carboxy-bicyclo (2,2,1)-heptane. This defect was confirmed by studies with two naturally occurring L-system amino acids, leucine and phenylalanine. This specific abnormality of membrane transport by chronic lymphocytic leukemic B lymphocytes is not shared by other B lymphocyte types, and thus appears to be related to the neoplastic nature of the leukemic B cells rather than to their immunologic subtype.

Full text

PDF
17

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Autio K., Turunen O., Erämaa E., Penttilä O., Schröder J. Human chronic lymphocytic leukaemia. Surface markers and activation of lymphocytes. Scand J Haematol. 1979 Oct;23(4):265–271. doi: 10.1111/j.1600-0609.1979.tb02860.x. [DOI] [PubMed] [Google Scholar]
  2. Christensen H. N., Handlogten M. E., Lam I., Tager H. S., Zand R. A bicyclic amino acid to improve discriminations among transport systems. J Biol Chem. 1969 Mar 25;244(6):1510–1520. [PubMed] [Google Scholar]
  3. Dantzig A. H., Adelberg E. A., Slayman C. W. Properties of two mouse lymphocyte cell lines genetically defective in amino acid transport. J Biol Chem. 1979 Sep 25;254(18):8988–8993. [PubMed] [Google Scholar]
  4. Davis S. The variable pattern of circulating lymphocyte subpopulations in chronic lymphocytic leukemia. N Engl J Med. 1976 May 20;294(21):1150–1153. doi: 10.1056/NEJM197605202942104. [DOI] [PubMed] [Google Scholar]
  5. Frengley P. A., Lichtman M. A., Peck W. A. Adaptive enhancement of amino acid transport in human leukemia leukocytes: studies with alpha-aminoisobutyric acid. J Lab Clin Med. 1975 Dec;86(6):984–986. [PubMed] [Google Scholar]
  6. Guidotti G. G., Borghetti A. F., Gazzola G. C. The regulation of amino acid transport in animal cells. Biochim Biophys Acta. 1978 Dec 15;515(4):329–366. doi: 10.1016/0304-4157(78)90009-6. [DOI] [PubMed] [Google Scholar]
  7. Handwerger B. S., Schwartz R. H. Separation of murine lymphoid cells using nylon wool columns. Recovery of the B cell-enriched population. Transplantation. 1974 Dec;18(6):544–548. doi: 10.1097/00007890-197412000-00013. [DOI] [PubMed] [Google Scholar]
  8. Kornfeld S. Decreased phytohemagglutinin receptor sites in chronic lymphocytic leukemia. Biochim Biophys Acta. 1969 Dec 30;192(3):542–545. doi: 10.1016/0304-4165(69)90409-7. [DOI] [PubMed] [Google Scholar]
  9. LaMantia K., Conklyn M., Quagliata F., Silber R. Lymphocyte 5'-nucleotidase: absence of detectable protein in chronic lymphocytic leukemia. Blood. 1977 Oct;50(4):683–689. [PubMed] [Google Scholar]
  10. Segel G. B., Lichtman M. A. Amino acid transport in human lymphocytes: distinctions in the enhanced uptake with PHA treatment or amino acid deprivation. J Cell Physiol. 1981 Feb;106(2):303–308. doi: 10.1002/jcp.1041060217. [DOI] [PubMed] [Google Scholar]
  11. Segel G. B., Lichtman M. A. Decreased L-system for amino acid transport in chronic lymphocytic leukemic lymphocytes. J Biol Chem. 1982 Aug 25;257(16):9255–9257. [PubMed] [Google Scholar]
  12. Segel G. B., Lichtman M. A. Decreased membrane potassium permeability and transport in human chronic leukemic and tonsillar lymphocytes. J Cell Physiol. 1977 Nov;93(2):277–284. doi: 10.1002/jcp.1040930213. [DOI] [PubMed] [Google Scholar]
  13. Segel G. B., Lichtman M. A., Gordon B. R., MacPherson J. L., Nusbacher J. Plateletpheresis residues: a source of large quantities of human blood lymphocytes. Transfusion. 1976 Sep-Oct;16(5):455–459. doi: 10.1046/j.1537-2995.1976.16577039302.x. [DOI] [PubMed] [Google Scholar]
  14. Segel G. B., Simon W., Lichtman M. A. A multicomponent analysis of amino acid transport systems in human lymphocytes. 1. Kinetic parameters of the A and L systems and pathways of uptake of naturally occurring amino acids in blood lymphocytes. J Cell Physiol. 1983 Sep;116(3):372–378. doi: 10.1002/jcp.1041160315. [DOI] [PubMed] [Google Scholar]
  15. Segel G. B., Simon W., Lichtman M. A. Regulation of sodium and potassium transport in phytohemagglutinin-stimulated human blood lymphocytes. J Clin Invest. 1979 Sep;64(3):834–841. doi: 10.1172/JCI109531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Simmonds M. A., Sobczak G., Hauptman S. P. Chronic lymphocytic leukemia cells lack the 185,000-dalton macromolecular insoluble cold globulin present on normal B lymphocytes. J Clin Invest. 1981 Mar;67(3):624–631. doi: 10.1172/JCI110076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Smith J. B., Knowlton R. P., Koons L. S. Immunologic studies in chronic lymphocytic leukemia: defective stimulation of T-cell proliferation in autologous mixed lymphocyte culture. J Natl Cancer Inst. 1977 Mar;58(3):579–585. doi: 10.1093/jnci/58.3.579. [DOI] [PubMed] [Google Scholar]
  18. Speckart S. F., Boldt D. H., MacDermott R. P. Chronic lymphatic leukemia (CLL): cell surface changes detected by lectin binding and their relation to altered glycosyltransferase activity. Blood. 1978 Oct;52(4):681–695. [PubMed] [Google Scholar]
  19. Stark R., Liebes L. F., Nevrla D., Conklyn M., Silber R. Decreased actin content of lymphocytes from patients with chronic lymphocytic leukemia. Blood. 1982 Mar;59(3):536–541. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES